Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Sep 22, 2020
Date Accepted: Nov 9, 2020
Date Submitted to PubMed: Nov 25, 2020
SARS-CoV-2 and COVID-19: a scientometric analysis of research output and international cooperation
ABSTRACT
Background:
The coronavirus disease 2019 (COVID-19) pandemic has led to immediate and massive research efforts worldwide. Methods and
Results:
This analysis aimed to correlate the severity of the COVID-19 outbreak with its related scientific output per region. All articles related to the COVID-19 pandemic were retrieved from Web-of-Science and analyzed utilizing the web application SciPE (Science-Performance-Evaluation), allowing large data scientometric analyses regarding global geographical distribution of scientific output. A total of 7,185 articles, including 2,898 articles, 2,275 editorial materials, 2,646 early access, 1,621 letters and 711 reviews and other contributions were extracted. The top three countries involved in COVID-19 research were the United States (US), China, and Italy. The regional number of confirmed COVID-19 cases or deaths correlated with the scientific research efforts. The US was most active in terms of collaborative efforts, sharing a significant amount of manuscripts with the United Kingdom (UK), China, and Italy. For China, the US was the frequent cooperating nation, followed by the UK. Conclusion: The research landscape related to COVID-19 is rapidly developing and is driven by countries with a general strong research output but is also strongly affected by countries with high prevalence of COVID-19 cases. The US dominates international collaborative efforts.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.